Evaluation of an inpatient automatic dose reduction protocol for concentrated insulin glargine upon therapeutic interchange to insulin detemir on hypoglycemia rates
A protocol requiring a minimum 20% dose reduction from iGlar300 to inpatient iDet100 reduced the incidence of hypoglycemia. Health systems should consider adopting a similar approach to reduce the occurrence of hypoglycemia upon interchange.
Authors
- Denise Kelley (ORCID: https://orcid.org/0000-0002-2838-7222)
- Kristin M. Janzen (ORCID: https://orcid.org/0000-0002-8669-3527)
- Janci Addison (ORCID: https://orcid.org/0000-0002-6601-1031)
- Steven Wulfe (ORCID: https://orcid.org/0000-0003-3309-7614)
- Brittany Glowacki
Institutions
- Austin College (US)
- Seton Healthcare Family (US)
- Ascension (US)
- Texas College (US)
Publication Details
- Journal
- American Journal of Health-System Pharmacy
- Published
- 2024-11-21
- DOI
- https://doi.org/10.1093/ajhp/zxae346
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00